Navitus Health Solutions Partners with Sempre Health to Help Members Save on & Adhere to Medications

July 28, 2020

Members pay less by filling chronic disease prescriptions consistently and on time

MADISON, Wis., July 28, 2020 – As plan sponsors continuously look for ways to reduce medication costs and improve member health, Navitus Health Solutions, a full pass-through pharmacy benefits management company, announced today that it is offering a new SMS-based program that will allow eligible Navitus members to earn discounts on their prescription copays by taking their medications as prescribed.

Medication costs can be a barrier to patients taking their medication as directed by their doctor and pharmacist. In fact, according to the U.S. Food & Drug Administration, medication is not taken as prescribed 50 percent of the time, and one in four Americans say it is difficult to afford their medications.1,2 As a result, it is estimated that non-adherence to medication leads to $100-$290 billion in direct and indirect costs annually.3

To improve adherence and affordability for chronic disease medications, Navitus is partnering with Sempre Health, to offer point-of-sale copay discounts and an SMS-based engagement program to incentivize its members. Sempre’s program lowers copays when members fill their prescriptions consistently and on time, reminds members when it’s time for a refill and can even submit refill requests on the member’s behalf.

“Cost and medication adherence are two of the largest challenges in health care,” said Navitus SVP, and Chief Pharmacy Officer Brent Eberle. “We’re excited to offer our clients an innovative technology-based approach that enables their members to save on copays for specific drugs, when they take their medication as prescribed.”

Navitus will introduce Sempre to clients as a free program in August 2020. As members enroll, their copay discounts will be immediately available on eligible medications at the pharmacy they normally use. If members elect to refill elsewhere, they can show their pharmacist a text from Sempre to take advantage of the program discounts. Each time members refill their eligible prescription on time, their discounts can grow—saving them an average of 45% per year on their annual prescription costs and improving member adherence by 15-19%.

“Like Navitus, Sempre is committed to improving member health and making prescriptions more affordable,” said Anurati Mathur, founder and CEO of Sempre Health. “By providing escalating savings directly to patients, Sempre engages and incentivizes those who prioritize medication adherence and make healthy lifestyle choices. Partnerships like this with Navitus allow us to bring those savings to more people throughout the country, especially while COVID-19 continues to put pressure on our health system and create uncertainty in patients’ lives.”

To learn more about Navitus’ comprehensive suite of programs and services for members and plan sponsors, visit www.navitus.com.

About Navitus

Navitus Health Solutions is owned by SSM Health and Costco Wholesale Corporation and serves as a full pass-through pharmacy benefit manager (PBM) and industry alternative to traditional models. As such, Navitus is committed to taking the unnecessary costs out of pharmacy benefits to make prescriptions more affordable for its over 650 plan sponsors (e.g., employers, health plans, unions, governments, etc.) and their 6.2 million members. By combining a unique pass-through approach that returns 100% of rebates and discounts with a focus on lowest-net-cost medications and comprehensive clinical care programs, Navitus helps reduce costs and improve member health. To learn more about Navitus, call (877) 571-7500 or visit www.navitus.com.

About Sempre Health

Sempre Health works with leading health plans and pharmaceutical companies to reduce the cost of copayments for patients who refill their prescriptions on time. By combining technology, behavioral science and dynamic pricing, Sempre Health aims to boost all of its members’ medication adherence to meet or exceed 80 percent — the widely acknowledged gold standard. Doing so will dramatically improve the health of millions of people and save hundreds of billions of dollars in avoidable medical costs. For more information visit: www.semprehealth.com.

For media inquiries:

Navitus Health Solutions
Contact [email protected]

Sempre Health
Contact [email protected]

1U.S Food & Drug Administration: Why You Need to Take Your Medications as Prescribed or Instructed https://www.fda.gov/drugs/special-features/why-you-need-to-take-your-medications-prescribed-or-instructed#:~text=The%20High%20Cost%20of%20Not%20in%20this%20country
Original source active as of publication date. For current and comparable data, please see: Montero A, Hamel L, Brodie M, Kearney A. Americans’ Challenges with Health Care Costs. Kaiser Family Foundation. Published March 01, 2024. https://www.kff.org/health-costs/issue-brief/americans-challenges-with-health-care-costs/
2Henry J Kaiser Family Foundation: Data Note: Americans’ Challenges with Health Care Costs (https://www.kff.org/health-costs/issue-brief/data-note-americans-challenges-health-care-costs/)
3NEJM: Taking Our Medicine — Improving Adherence in the Accountability Era (https://www.nejm.org/doi/pdf/10.1056/NEJMp1307084)

More About BRENT EBERLE

As Senior Vice President, Chief Pharmacy Officer, Brent oversees Navitus’ health strategies division, which is responsible for clinical and population health initiatives, drug utilization review programs, formulary and rebate management, and specialty pharmacy operations.

Stay Informed and Connected

Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.

Examining Trends that Drive Informed Decisions

Now Available: 8th Annual Drug Trend Report

See the latest results and access industry insights you need to navigate current trend drivers.

Related blogs

Navigating Healthcare and Improving Outcomes

Real-world Data Demonstrates Successful Transitions from Humira to Biosimilars

Real-world Data Demonstrates Successful Transitions from Humira to Biosimilars

Authors: Justin Arzt, PharmD; Agata Siwak, PharmD, MSBA; Marnie Wickizer, PharmD, AE-C, CDCES; Ryan Schmidt, PharmD; Robert Topp, RN, PhD; Matt Hustad, PharmD All authors are employees of Navitus Health Solutions. Abstract Adalimumab biosimilar adoption…

PBM 101: Why the Model Matters

PBM 101: Why the Model Matters

In the pharmaceutical and healthcare industry, pharmacy benefit managers (PBMs) are conduits of expertise, analytics and savings opportunities, poised to deliver exceptional health care while driving down costs. They coordinate between drug manufacturers,…

Associate Resource Group Spotlight: Green Team

Associate Resource Group Spotlight: Green Team

The Green Team believes that small changes lead to significant impact. Whether its reducing waste, conserving energy or implementing eco-friendly initiatives, they serve as an internal hub for expertise regarding environmental sustainability….

PBM 101: The Three PBM Business Models

PBM 101: The Three PBM Business Models

In the pharmaceutical and healthcare industry, pharmacy benefit managers (PBMs) are regarded by the media as intermediaries between drug manufacturers, pharmacies, health plans and plan sponsors. But they’re so much more than that. PBMs act as conduits…

An Automated Approach to Diagnosis Verification of GLP-1 RA for Type 2 Diabetes Mellitus (T2DM)

An Automated Approach to Diagnosis Verification of GLP-1 RA for Type 2 Diabetes Mellitus (T2DM)

This study examines the impact of implementing an automated point-of-sale diagnosis verification system for glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compared to traditional utilization management approaches….

Navitus to Remove Stelara® from Formulary July 1, 2025, Adds Biosimilars to Drive $120 Million in Savings 

Navitus to Remove Stelara® from Formulary July 1, 2025, Adds Biosimilars to Drive $120 Million in Savings 

As the nation’s first 100% transparent, pass-through PBM, we continue to advance medication affordability by prioritizing upfront, real-time savings over rebated models….

Achieving Outstanding Results with Tailored Network Strategies

Achieving Outstanding Results with Tailored Network Strategies

A medium-sized city in Michigan with 1,350 members was seeking ways to lower its pharmacy benefit costs, which were growing under its existing traditional pharmacy benefit manager (PBM). With its member covered by a two-tier, open formulary including…

Breaking Through Barriers with Value-Based Plan Design

Breaking Through Barriers with Value-Based Plan Design

Facing increased pharmacy benefit expenses, Blain’s Farm and Fleet, a Midwestern employer group, desired to improve plan performance. Specifically it was interested in educating eligible members about the benefits available to them, promoting cost-effective…

Finding a Solution to Lower Prescription Drug Costs

Finding a Solution to Lower Prescription Drug Costs

The Rural Arizona Group Health Trust (RAGHT) wanted to gain better control of its escalating drug trend with its large, traditional pharmacy benefit manager (PBM). Having only worked with traditional PBMs in the past, RAGHT was interested in exploring…

previous arrow
next arrow